Somatostatin Analogs and Tumor Localization Do Not Influence Vitamin D Concentration in Patients with Neuroendocrine Tumors

References

• Hossein-nezhad A, Holick MF: Vitamin D for health: a global perspective. Mayo Clin Proc 88, 720–755, 2013.
   PubMed Web of Science ®Google Scholar
• Dusso AS, Brown AJ, Slatopolsky E: Vitamin D. Am J Physiol Renal Physiol 289, F8–28, 2005.
   PubMed Web of Science ®Google Scholar
• Yang L, Ma J, Zhang X, Fan Y, Wang L: Protective role of the vitamin D receptor. Cell Immunol 279, 160–166, 2012.
   PubMed Web of Science ®Google Scholar
• Holick MF: Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 80(6 Suppl), 1678S–1688S, 2004.
   PubMed Web of Science ®Google Scholar
• DeLuca HF: Evolution of our understanding of vitamin D. Nutr Rev 66(Suppl 2), S73–87, 2008.
   PubMed Web of Science ®Google Scholar
• Cranney A, Weiler HA, O'Donnell S, Puil L: Summary of evidence-based review on vitamin D efficacy and safety in relation to bone health. Am J Clin Nutr 88, 513S–519S, 2008.
   PubMed Web of Science ®Google Scholar
• Ceglia L, Harris SS: Vitamin D and its role in skeletal muscle. Calcif Tissue Int 92, 151–162, 2013.
   PubMed Web of Science ®Google Scholar
• Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C: Vitamin D: modulator of the immune system. Curr Opin Pharmacol 10, 482–496, 2010.
   PubMed Web of Science ®Google Scholar
• Pludowski P, Holick MF, Pilz S, Wagner CL, Hollis BW et al.: Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence. Autoimmun Rev 12, 976–989, 2013.
   PubMed Web of Science ®Google Scholar
• Holick MF, Chen TC: Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 87, 1080S–1086S, 2008.
   PubMed Web of Science ®Google Scholar
• Kulke MH, Benson AB 3rd, Bergsland E, Berlin JD, Blaszkowsky LS et al.: National Comprehensive Cancer Networks: Neuroendocrine tumors. J Natl Compr Canc Netw 10, 724–764, 2012.
   PubMed Web of Science ®Google Scholar
• Taal BG, Visser O: Epidemiology of neuroendocrine tumours. Neuroendocrinology 80(Suppl 1), 3–7, 2004.
   PubMedGoogle Scholar
• Modlin IM, Lye KD, Kidd M: A 5-decade analysis of 13,715 carcinoid tumors. Cancer 97, 93–959, 2003.
   Web of Science ®Google Scholar
• Nobels FR, Kwekkeboom DJ, Coopmans W, Schoenmakers CH, Lindemans J et al.: Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones. J Clin Endocrinol Metab 82, 2622–2628, 1997.
   PubMed Web of Science ®Google Scholar
• Singh S, Law C: Chromogranin A: a sensitive biomarker for the detection and post-treatment monitoring of gastroenteropancreatic neuroendocrine tumors. Expert Rev Gastroenterol Hepatol 6, 313–334, 2012.
   PubMed Web of Science ®Google Scholar
• Wolin EM: The expanding role of somatostatin analogs in the management of neuroendocrine tumors. Gastrointest Cancer Res 5, 161–168, 2012.
   PubMedGoogle Scholar
• Rinke A, Müller HH, Schade-Brittinger C, Klose KJ, Barth P et al.: PROMID Study Group: Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group. J Clin Oncol 27, 4656–4663, 2009.
   PubMed Web of Science ®Google Scholar
• Caplin ME, Pavel M, Ćwikła JB, Phan AT, Raderer M et al.: CLARINET Investigators: Lanreotide in metastatic enteropancreatic neuroendocrine tumors. N Engl J Med 371, 224–233, 2014.
   PubMed Web of Science ®Google Scholar
• Elecsys Vitamin D total fact sheet: Elecsys ® Vitamin D total assay. Electro-chemiluminescence binding assay (ECLIA) for the in-vitro determination of total 25-hydroxyvitamin D. Roche. 2012. Available from http://www.cobas.com/content/dam/cobas_com/pdf/product/Elecsys-Vitamin-D-total-assay/Elecsys%20Vitamin%20D%20total%20Factsheet.pdf. Accessed June 2015.
   Google Scholar
• Binkley N, Wiebe D: Clinical controversies in vitamin D: 25(OH)D measurement, target concentration, and supplementation. J Clin Densitom 16, 402–408, 2013.
   PubMed Web of Science ®Google Scholar
• Wielders JP, Carter GF, Eberl H, Morris G, Jürgen Roth H et al.: Automated Competitive Protein-Binding Assay for Total 25-OH Vitamin D, Multicenter Evaluation and Practical Performance. J Clin Lab Anal 2014, doi: 10.1002/jcla.21793.
   PubMed Web of Science ®Google Scholar
• Haderslev KV, Jeppesen PB, Sorensen HA, Mortensen PB, Staun M: Vitamin D status and measurements of markers of bone metabolism in patients with small intestinal resection. Gut 52, 653–658, 2003.
   PubMed Web of Science ®Google Scholar
• Iruzubieta P, Terán Á, Crespo J: Fábrega E: Vitamin D deficiency in chronic liver disease. World J Hepatol 6, 901–915, 2014.
   PubMedGoogle Scholar
• Ho PJ, Boyajy LD, Greenstein E, Barkan AL: Effect of chronic octreotide treatment on intestinal absorption in patients with acromegaly. Dig Dis Sci 38, 309–315, 1993.
   PubMed Web of Science ®Google Scholar
• Lamrani A, Vidon N, Sogni P, Nepveux P, Catus F et al.: Effects of lanreotide, a somatostatin analogue, on postprandial gastric functions and biliopancreatic secretions in humans. Br J Clin Pharmacol 43, 65–70, 1997.
   PubMed Web of Science ®Google Scholar
• von der Ohe MR, Camilleri M, Kvols LK, Thomforde GM: Motor dysfunction of the small bowel and colon in patients with the carcinoid syndrome and diarrhea. N Engl J Med 329, 1073–1078, 1993.
   PubMed Web of Science ®Google Scholar
• Fiebrich HB, Van Den Berg G, Kema IP, Links TP, Kleibeuker JH et al.: Deficiencies in fat-soluble vitamins in long-term users of somatostatin analogue. Aliment Pharmacol Ther 32, 1398–1404, 2010.
   PubMed Web of Science ®Google Scholar
• Ajmal A, Haghshenas A, Attarian S, Barake M, Tritos NA et al.: The effect of somatostatin analogs on vitamin D and calcium concentrations in patients with acromegaly. Pituitary 17, 366–373, 2014.
   PubMed Web of Science ®Google Scholar
• Yetley EA: Assessing the vitamin D status of the US population. Am J Clin Nutr 88, 558S–564S, 2008.
   PubMed Web of Science ®Google Scholar
• Bruyère O, Malaise O, Neuprez A, Collette J, Reginster JY: Prevalence of vitamin D inadequacy in European postmenopausal women. Curr Med Res Opin 23, 1939–1944, 2007.
   PubMed Web of Science ®Google Scholar
• Braegger C, Campoy C, Colomb V, Decsi T, Domellof M et al.: ESPGHAN Committee on Nutrition: Vitamin D in the healthy European paediatric population. J Pediatr Gastroenterol Nutr 56, 692–701, 2013.
   PubMed Web of Science ®Google Scholar
• van den Bemd GJ, Chang GT: Vitamin D and vitamin D analogs in cancer treatment. Drug Targets 3, 85–94, 2002.
   PubMed Web of Science ®Google Scholar